![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|8|25|2279-2284
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.8, Iss.25, 2002-11, pp. : 2279-2284
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New developments in cancer therapy: molecularly targeted agents
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Progress in Azole Compounds as Antimicrobial Agents
Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 2, 2017-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Blockers in Heart Failure: The New Wave of Clinical Trials
By Krum H.
Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. :